Syndax Pharmaceuticals Inc (SNDX) — Cash Flow Quality Index
Syndax Pharmaceuticals Inc (SNDX) has a Cash Flow Quality Index of 1.05x as of December 2021. Operating cash flow of $100.71 Million exceeds net income of $96.20 Million, indicating high earnings quality where cash backs reported profits. Explore how efficiently does Syndax Pharmaceuticals Inc generate cash to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Syndax Pharmaceuticals Inc Cash Flow Quality Index (2021–2021)
Historical Cash Flow Quality Index for Syndax Pharmaceuticals Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check cash flow reinvestment rate of Syndax Pharmaceuticals Inc to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Syndax Pharmaceuticals Inc (2021–2021)
Year-by-year earnings quality comparison for Syndax Pharmaceuticals Inc. For live market cap and the full company financial profile, see Syndax Pharmaceuticals Inc market capitalisation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2021 | 1.17x | $29.13 Million | $24.93 Million | — |